JP2019089796A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019089796A5 JP2019089796A5 JP2019009896A JP2019009896A JP2019089796A5 JP 2019089796 A5 JP2019089796 A5 JP 2019089796A5 JP 2019009896 A JP2019009896 A JP 2019009896A JP 2019009896 A JP2019009896 A JP 2019009896A JP 2019089796 A5 JP2019089796 A5 JP 2019089796A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- receptor antagonist
- kit
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 239000000938 histamine H1 antagonist Substances 0.000 claims 5
- 229960001803 cetirizine Drugs 0.000 claims 4
- ZKLPARSLTMPFCP-UHFFFAOYSA-N levocetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 claims 4
- 239000006186 oral dosage form Substances 0.000 claims 4
- 239000003485 histamine H2 receptor antagonist Substances 0.000 claims 3
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-ium-1-yl]ethoxy]acetate Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- XUFQPHANEAPEMJ-UHFFFAOYSA-N Famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 claims 2
- 229960001596 Famotidine Drugs 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 229960001508 levocetirizine Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 208000004232 Enteritis Diseases 0.000 claims 1
- 210000000138 Mast Cells Anatomy 0.000 claims 1
- 201000009840 acute diarrhea Diseases 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 201000008286 diarrhea Diseases 0.000 claims 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
Claims (12)
- Ｈ１受容体アンタゴニスト及びＨ２受容体アンタゴニストを含むキットであって、
前記Ｈ１受容体アンタゴニストが、セチリジン、レボセチリジン、又はそれらの混合物を含む、キット。 - 医薬組成物であって、
Ｈ１受容体アンタゴニスト及びＨ２受容体アンタゴニストを含み、
前記Ｈ１受容体アンタゴニストが、セチリジン、レボセチリジン、又はそれらの混合物を含む、医薬組成物。 - 患者において下痢を治療するのに使用するための、請求項１に記載のキット又は請求項２に記載の医薬組成物。
- 前記患者が、肥満細胞性腸炎に罹患していない、請求項３に記載のキット又は請求項３に記載の医薬組成物。
- 前記患者が、急性下痢に罹患している、請求項３若しくは４に記載のキット又は請求項３若しくは４に記載の医薬組成物。
- 前記Ｈ１受容体アンタゴニスト及び前記Ｈ２受容体アンタゴニストが、同時に投与される、請求項１及び３〜５のいずれか一項に記載のキット又は請求項２〜５のいずれか一項に記載の医薬組成物。
- セチリジンが、５〜２０ｍｇの量で投与され、及び／又は、ファモチジンが、１０〜４０ｍｇの量で投与される、請求項１及び３〜６のいずれか一項に記載のキット又は請求項２〜６のいずれか一項に記載の医薬組成物。
- ファモチジン及びセチリジンが、単位剤形として一緒に投与される、請求項１及び３〜７のいずれか一項に記載のキット又は請求項２〜７のいずれか一項に記載の医薬組成物。
- 経口剤形である、請求項２〜８のいずれか一項に記載の医薬組成物。
- 前記経口剤形が、複数の単位剤形を含む、請求項９に記載の医薬組成物。
- 前記経口剤形が、ナトリウム、及び、グルコース又はグルコース含有サッカリドをさらに含む、請求項９又は１０に記載の医薬組成物。
- 前記経口剤形が、経口補水溶液をさらに含む、請求項９〜１１のいずれか一項に記載の医薬組成物。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361782608P | 2013-03-14 | 2013-03-14 | |
| US61/782,608 | 2013-03-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018054088A Division JP6473254B2 (ja) | 2013-03-14 | 2018-03-22 | 下痢を治療するための製品及び方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020184294A Division JP2021046400A (ja) | 2013-03-14 | 2020-11-04 | 下痢を治療するための製品及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019089796A JP2019089796A (ja) | 2019-06-13 |
| JP2019089796A5 true JP2019089796A5 (ja) | 2019-10-24 |
| JP6790140B2 JP6790140B2 (ja) | 2020-11-25 |
Family
ID=50680150
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502404A Active JP6313417B2 (ja) | 2013-03-14 | 2014-03-14 | 下痢を治療するための製品及び方法 |
| JP2018054088A Active JP6473254B2 (ja) | 2013-03-14 | 2018-03-22 | 下痢を治療するための製品及び方法 |
| JP2019009896A Active JP6790140B2 (ja) | 2013-03-14 | 2019-01-24 | 下痢を治療するための製品及び方法 |
| JP2020184294A Pending JP2021046400A (ja) | 2013-03-14 | 2020-11-04 | 下痢を治療するための製品及び方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502404A Active JP6313417B2 (ja) | 2013-03-14 | 2014-03-14 | 下痢を治療するための製品及び方法 |
| JP2018054088A Active JP6473254B2 (ja) | 2013-03-14 | 2018-03-22 | 下痢を治療するための製品及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020184294A Pending JP2021046400A (ja) | 2013-03-14 | 2020-11-04 | 下痢を治療するための製品及び方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US9717726B2 (ja) |
| EP (3) | EP3581205A3 (ja) |
| JP (4) | JP6313417B2 (ja) |
| KR (4) | KR102449977B1 (ja) |
| CN (2) | CN108939076A (ja) |
| AU (3) | AU2014239878B2 (ja) |
| BR (2) | BR122017004716A2 (ja) |
| CA (1) | CA2906005C (ja) |
| DK (1) | DK2968205T3 (ja) |
| ES (2) | ES2655505T3 (ja) |
| HK (2) | HK1213205A1 (ja) |
| HU (1) | HUE035201T2 (ja) |
| IL (3) | IL273377B2 (ja) |
| MX (2) | MX366329B (ja) |
| MY (1) | MY175326A (ja) |
| PL (1) | PL2968205T3 (ja) |
| PT (1) | PT2968205T (ja) |
| RU (1) | RU2015143475A (ja) |
| WO (1) | WO2014152420A2 (ja) |
| ZA (1) | ZA201708539B (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9717726B2 (en) * | 2013-03-14 | 2017-08-01 | Maregade Rx, LLC | Product and method for treating diarrhea |
| WO2015073573A1 (en) * | 2013-11-14 | 2015-05-21 | Jacobs Michael M | Compositions and methods for the prevention and treatment of alcohol-induced hangover syndrome |
| ES2953520T3 (es) | 2016-12-23 | 2023-11-14 | Maregade Rx Llc | Producto a baja dosis y método para el tratamiento de la diarrea |
| IT201900012645A1 (it) * | 2019-07-23 | 2021-01-23 | Eros Zanotti | Una composizione farmaceutica per l'uso nel trattamento delle chinetosi |
| US11424105B2 (en) * | 2019-08-05 | 2022-08-23 | Hitachi High-Tech Corporation | Plasma processing apparatus |
| WO2023049205A1 (en) * | 2021-09-22 | 2023-03-30 | Hista Rx Llc | Compositions and methods for treating and preventing interstitial cystitis |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204118A (en) | 1989-11-02 | 1993-04-20 | Mcneil-Ppc, Inc. | Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
| WO1995001792A1 (en) | 1993-07-06 | 1995-01-19 | Merck & Co., Inc. | H2 antagonist-antihistamine combinations |
| US6264984B1 (en) * | 1999-12-06 | 2001-07-24 | Bristol-Myers Squibb Company | Effervescent histamine H2 antagonist composition |
| US6656492B2 (en) * | 2000-06-30 | 2003-12-02 | Yamanouchi Pharmaceutical Co., Ltd. | Quick disintegrating tablet in buccal cavity and manufacturing method thereof |
| CN1294253C (zh) | 2000-11-30 | 2007-01-10 | 生物平衡公司 | 细菌菌株，加工过的植物提取物，含有它们的组合物，其制备方法及其治疗和工业应用 |
| NZ550723A (en) * | 2001-11-23 | 2008-06-30 | Janssen Pharmaceutica Nv | The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| SE528789C2 (sv) | 2004-09-10 | 2007-02-13 | Sandvik Intellectual Property | PVD-belagt skär av hårdmetall samt sätt att tillverka detta |
| US20070077300A1 (en) * | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
| US20090312358A1 (en) | 2006-03-22 | 2009-12-17 | Trustees Of Boston University | Method for management of diarrhea |
| US8207188B2 (en) | 2006-04-07 | 2012-06-26 | Michalis Nicolaou | Treatment of diseases modulated by a H4 receptor agonist |
| US20070254050A1 (en) * | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| US20090042972A1 (en) * | 2006-05-19 | 2009-02-12 | Somaxon Pharmaceuticals, Inc. | Methods of using low-dose doxepin for the improvement of sleep |
| EP2559434A3 (en) | 2007-02-12 | 2013-05-29 | Mike Nicolaou | Treatment of COPD using a histidine decarboxylase inhibitor sole or combined with an anti-H1 drug or with a leucotriene receptor antagonist |
| US20090074862A1 (en) * | 2007-04-13 | 2009-03-19 | Luigi Schioppi | Low-dose doxepin formulations and methods of making and using the same |
| US8263581B2 (en) | 2009-07-03 | 2012-09-11 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| US9856477B2 (en) | 2012-11-13 | 2018-01-02 | Codiak Biosciences, Inc. | Delivery of therapeutic agent |
| US9717726B2 (en) | 2013-03-14 | 2017-08-01 | Maregade Rx, LLC | Product and method for treating diarrhea |
| ES2953520T3 (es) | 2016-12-23 | 2023-11-14 | Maregade Rx Llc | Producto a baja dosis y método para el tratamiento de la diarrea |
-
2014
- 2014-03-13 US US14/209,937 patent/US9717726B2/en active Active
- 2014-03-14 EP EP19169633.5A patent/EP3581205A3/en active Pending
- 2014-03-14 CN CN201810755897.7A patent/CN108939076A/zh active Pending
- 2014-03-14 MY MYPI2015703092A patent/MY175326A/en unknown
- 2014-03-14 CA CA2906005A patent/CA2906005C/en active Active
- 2014-03-14 PT PT147224455T patent/PT2968205T/pt unknown
- 2014-03-14 PL PL14722445T patent/PL2968205T3/pl unknown
- 2014-03-14 EP EP17189072.6A patent/EP3269364B1/en active Active
- 2014-03-14 BR BR122017004716-7A patent/BR122017004716A2/pt not_active Application Discontinuation
- 2014-03-14 EP EP14722445.5A patent/EP2968205B1/en active Active
- 2014-03-14 ES ES14722445.5T patent/ES2655505T3/es active Active
- 2014-03-14 MX MX2017011532A patent/MX366329B/es unknown
- 2014-03-14 JP JP2016502404A patent/JP6313417B2/ja active Active
- 2014-03-14 KR KR1020217004881A patent/KR102449977B1/ko active IP Right Grant
- 2014-03-14 ES ES17189072T patent/ES2743604T3/es active Active
- 2014-03-14 IL IL273377A patent/IL273377B2/en unknown
- 2014-03-14 HU HUE14722445A patent/HUE035201T2/hu unknown
- 2014-03-14 WO PCT/US2014/027323 patent/WO2014152420A2/en active Application Filing
- 2014-03-14 BR BR112015022513A patent/BR112015022513A2/pt not_active Application Discontinuation
- 2014-03-14 KR KR1020207023569A patent/KR20200100211A/ko not_active Application Discontinuation
- 2014-03-14 KR KR1020157029028A patent/KR101884506B1/ko active IP Right Grant
- 2014-03-14 KR KR1020187021688A patent/KR20180088514A/ko not_active IP Right Cessation
- 2014-03-14 RU RU2015143475A patent/RU2015143475A/ru not_active Application Discontinuation
- 2014-03-14 DK DK14722445.5T patent/DK2968205T3/da active
- 2014-03-14 CN CN201480022471.0A patent/CN105324112B/zh active Active
- 2014-03-14 AU AU2014239878A patent/AU2014239878B2/en active Active
- 2014-03-14 MX MX2015011885A patent/MX350814B/es active IP Right Grant
-
2015
- 2015-09-09 IL IL241372A patent/IL241372B/en active IP Right Grant
-
2016
- 2016-02-04 HK HK16101359.5A patent/HK1213205A1/zh unknown
- 2016-09-06 US US15/257,674 patent/US10034875B2/en active Active
-
2017
- 2017-10-24 AU AU2017251701A patent/AU2017251701B2/en active Active
- 2017-12-13 IL IL256300A patent/IL256300B/en active IP Right Grant
- 2017-12-15 ZA ZA2017/08539A patent/ZA201708539B/en unknown
-
2018
- 2018-03-22 JP JP2018054088A patent/JP6473254B2/ja active Active
- 2018-05-28 HK HK18106976.5A patent/HK1247557B/zh unknown
- 2018-07-06 US US16/029,384 patent/US11058681B2/en active Active
-
2019
- 2019-01-24 JP JP2019009896A patent/JP6790140B2/ja active Active
- 2019-02-28 AU AU2019201412A patent/AU2019201412A1/en not_active Abandoned
-
2020
- 2020-11-04 JP JP2020184294A patent/JP2021046400A/ja active Pending
-
2021
- 2021-05-28 US US17/333,525 patent/US20220047583A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019089796A5 (ja) | ||
| HRP20160189T1 (hr) | Liječenje crohnove bolesti lakvinimodom | |
| JP5386173B2 (ja) | 閉経前の性的欲求障害の治療のためのフリバンセリンの使用 | |
| JP2009525343A5 (ja) | ||
| JP2019503365A5 (ja) | ||
| JP2016106150A5 (ja) | ||
| JP2006104221A5 (ja) | ||
| JP2005512995A5 (ja) | ||
| JP2017528507A5 (ja) | ||
| JP2012502037A5 (ja) | ||
| EP2444072A3 (en) | Non-mucoadhesive film dosage forms | |
| JP2015515475A5 (ja) | ||
| HRP20131120T1 (hr) | Farmaceutski pripravak koji sadrži (1s)-1,5-anhidro-1-[5-(4-etoksibenzil)-2-metoksi-4-metilfenil]-1-tio-d-glucitol i metformin, te njegova uporaba za lijeäśenje dijabetesa | |
| JP2015511609A5 (ja) | ||
| JP2009541348A5 (ja) | ||
| JP2015514739A5 (ja) | ||
| RU2015143475A (ru) | Продукт и способ лечения диареи | |
| JP2018039810A5 (ja) | ||
| NZ591408A (en) | Paracetamol and Calcium carbonate composition | |
| JP2012502915A5 (ja) | ||
| RU2015127834A (ru) | Способы лечения диабета путем введения антагониста рецептора глюкагона в сочетании с ингибитором поглощения холестерина | |
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| EA201071138A1 (ru) | Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона | |
| HRP20130225T1 (hr) | Formulacija s odgođenim otpuštanjem koja sadrži 3-(2-dimetilaminometilcikloheksil) fenol | |
| RU2005105302A (ru) | Композиция бицифадина |